Your browser doesn't support javascript.
loading
Initiation of anti-osteoporotic drugs in high-risk female patients starting glucocorticoid treatment: a population study in Norway.
Apalset, Ellen M; Lunde, Astrid; Hoff, Mari; Ehrenstein, Vera; Tell, Grethe S.
Afiliação
  • Apalset EM; Department of Global Public Health and Primary Care, University of Bergen, Kalfarveien 31, N-5018, Bergen, Norway.
  • Lunde A; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease, Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
  • Hoff M; Department of Global Public Health and Primary Care, University of Bergen, Kalfarveien 31, N-5018, Bergen, Norway. astrid.lunde@uib.no.
  • Ehrenstein V; Department of Neuromedicine and Movement Science, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Tell GS; Department of Public Health and Nursing, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Arch Osteoporos ; 15(1): 121, 2020 08 05.
Article em En | MEDLINE | ID: mdl-32757143

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Glucocorticoides Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Glucocorticoides Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article